test-2 - Physician's Channel - Mount Sinai New York

Skip to main content

Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. Mount Sinai Physician’s Channel will show you some of the innovative procedures, developments in patient care, and complex cases that are being handled in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field.

Refer a Patient Online

Or call 212-241-4983

View New Content

Featured Content

Optical Coherence Tomography May Improve Safety and Outcomes for Stenting Procedures in Heart Disease Patients Compared to Conventional Angiography

Optical Coherence Tomography May Improve Safety and Outcomes for Stenting Procedures in Heart Disease Patients Compared to Conventional Angiography

Mount Sinai Receives Significant Funding to Study Which Coronary Revascularization Procedure Best Improves Survival and Quality of Life for Women and Underserved Minority Groups

Mount Sinai Receives Significant Funding to Study Which Coronary Revascularization Procedure Best Improves Survival and Quality of Life for Women and Underserved Minority Groups

Mount Sinai's George Dangas, MD, PhD, Named President of Society for Cardiovascular Angiography & Interventions

Mount Sinai's George Dangas, MD, PhD, Named President of Society for Cardiovascular Angiography & Interventions

Transcatheter Repair for Patients with Tricuspid Regurgitation Is Found Superior to Medical Therapy

Transcatheter Repair for Patients with Tricuspid Regurgitation Is Found Superior to Medical Therapy

New Content |view more

Endocrine, Diabetes and Bone Disease Specialty Report 2023

Endocrine, Diabetes and Bone Disease Specialty Report 2023

The Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at the Icahn School of Medicine at Mount Sinai is dedicated to advancing the understanding and treatment of diabetes, obesity, conditions affecting ...

JDRF Recognizes Mount Sinai’s Contribution to Diabetes Research and Patient Care

JDRF Recognizes Mount Sinai’s Contribution to Diabetes Research and Patient Care

Mount Sinai was honored by the Juvenile Diabetes Research Foundation at their annual Promise Ball for its type 1 diabetes research and patient care, with particular recognition of Carol J. Levy, MD, and Andrew F. Stewart, MD.

Study Is Investigating Role of Pituitary Hormone Deficiency in Post-COVID Fatigue

Study Is Investigating Role of Pituitary Hormone Deficiency in Post-COVID Fatigue

Mount Sinai’s Center for Post-COVID Care is part of a novel, multisite study that is investigating whether abnormal pituitary hormone levels are implicated in post-COVID fatigue, a prevalent and debilitating condition.

Research Roundup: Diabetes, Obesity and Metabolism Institute

Research Roundup: Diabetes, Obesity and Metabolism Institute

In 2022, investigators advanced the understanding of a broad spectrum of topics relevant to diabetes, metabolism, and obesity, including the central nervous system control of metabolism and therapies to regenerate pancreatic beta cells.

Message From the Chief

Message From the Chief

The Division of Endocrinology, Diabetes and Bone Disease continued to distinguish itself in patient care and research over the past year.

Researcher Awarded NIH Grant to Study Association Between Triglycerides and Triple Negative Breast Cancer

Researcher Awarded NIH Grant to Study Association Between Triglycerides and Triple Negative Breast Cancer

Emily Gallagher, MD, PhD, received a Method to Extend Research in Time (MERIT) Award from the National Cancer Institute to study the role of high triglyceride levels in driving triple negative breast cancer growth and metastasis.

Automated Insulin Delivery Shows Promise in Type 2 Diabetes

Automated Insulin Delivery Shows Promise in Type 2 Diabetes

Use of an automated insulin delivery system improved glucose control among people with type 2 diabetes, representing a potential option for those who are struggling to keep their glucose levels in range.

Mount Sinai Team Uses Novel Treatment Approach for Antibody-Mediated Insulin Resistance in a Patient With Cirrhosis

Mount Sinai Team Uses Novel Treatment Approach for Antibody-Mediated Insulin Resistance in a Patient With Cirrhosis

In an unusual and complex case, a multidisciplinary team developed a treatment for a patient with end-stage liver disease and insulin antibody-mediated insulin resistance.

Calls for Further Study to Fill Knowledge Gaps on Cardiometabolic Risk in PCOS

Calls for Further Study to Fill Knowledge Gaps on Cardiometabolic Risk in PCOS

Women with PCOS have increased prevalence rates of type 2 diabetes and metabolic syndrome, important risk factors for cardiovascular disease.

Mount Sinai Develops Protocols for Cushing Syndrome Due to Ectopic Production of ACTH

Mount Sinai Develops Protocols for Cushing Syndrome Due to Ectopic Production of ACTH

Alice C. Levine, MD, convened an interdisciplinary group of experts in adrenal disorders and neuroendocrine tumors to develop a clinical pathway for the management of Cushing syndrome due to ectopic adrenocorticotropin production.

Disrupting the DREAM Complex Enables Proliferation of Adult Human Pancreatic Beta Cells

Disrupting the DREAM Complex Enables Proliferation of Adult Human Pancreatic Beta Cells

Mount Sinai researchers demonstrated that small molecule DYRK1A inhibitors induce human beta cells to replicate by converting the repressive DREAM complex to its pro-proliferative MMB conformation—a crucial advance in the knowledge of this process.

Updated Standards Provide Crucial Guidance for Health of Transgender and Gender Diverse People

Updated Standards Provide Crucial Guidance for Health of Transgender and Gender Diverse People

Endocrinologists and other physicians gained important guidance, as the World Professional Association for Transgender Health released the first update of its standards of care in 10 years.